Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc.

EBS | NYSE
Chart Builder DCF Calculator
$6.55
-$0.25 (-3.68%)
At close: Sep 21, 2026, 4:00 PM ET
$6.55
$0 (0.00%)
After-hours: Sep 21, 2026, 4:18 PM ET
Fiscal Quarter
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Revenue
234.3M 156.1M 148.7M 231.1M 140.9M 222.2M 194.7M 293.8M 254.7M 300.4M 276.6M 270.5M 337.9M 164.3M 330.2M 239.9M 239.9M 307.5M 723.2M 329M 397.5M 343M
Cost of Revenue
97.1M 88.5M 102.1M 102M 83.4M 105.7M 58.2M 129.6M 320.2M 159.6M 107.4M 178.1M 214.5M 188.6M 215.9M 188.8M 220.9M 201.8M 295.6M 266.2M 276.7M 150.7M
Gross Profit
137.2M 67.6M 46.6M 129.1M 57.5M 116.5M 136.5M 164.2M -65.5M 140.8M 169.2M 92.4M 123.4M -24.3M 114.3M 51.1M 19M 105.7M 427.6M 62.8M 120.8M 192.3M
Operating Income
-125.1M 10.5M -16.6M 76.8M 500K 48.6M -9.5M 64.5M -203.5M 39.8M -43.8M -242.1M -292.9M -147.6M -55.3M -45.3M -75.8M 6.4M 277.4M -34.7M 14.5M 95.4M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 500K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-166.3M 13.4M -50.7M 57.6M -16.8M 92.7M -27.6M 142.4M -269.8M 12.1M -54.5M -265.9M -250.2M -160.6M -61.4M -67.2M -86.6M -3.8M 267.5M -45.5M 7.2M 85.2M
Net Income
-180.2M 6.8M -54.6M 51.2M -12M 68M -31.3M 114.8M -283.1M 9M -49.5M -263.4M -261.4M -186.2M -67M -87.1M -53.8M -3.7M 189.3M -32.7M 4.6M 69.7M
Selling & General & Admin
44.6M 46.6M 51.1M 38.8M 44M 52.7M 60.7M 75.9M 77.3M 84.8M 89.4M 79.7M 91.3M 96.3M 93.4M 81.8M 79.5M 84.8M 94.2M 82.1M 91.2M 80.9M
Research & Development
9.2M 10.5M 12.1M 13.5M 13M 15.2M 9.1M 13.8M 32.7M 15.1M 29.4M 15.3M 26M 40.7M 47M 42.2M 52.7M 46.4M 83M 49.6M 48.9M 52.5M
Other Expenses
208.5M n/a n/a n/a n/a n/a 76.2M 10M 28M 1.1M 94.2M 239.5M 299M -13.7M 29.2M -27.6M -37.4M -31.9M -27M -34.2M -33.8M -36.5M
Operating Expenses
262.3M 57.1M 63.2M 52.3M 57M 67.9M 146M 99.7M 138M 101M 213M 334.5M 416.3M 123.3M 169.6M 96.4M 94.8M 99.3M 150.2M 97.5M 106.3M 96.9M
Interest Expense
10M 11M 14.7M 15.2M 14.7M 14.7M 14.8M 8.3M 23.6M 24.3M 22.2M 19.7M 28.6M 17.9M 12.8M 8.5M 7.8M 8.2M 9M 8.4M 8.6M 8.5M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
359.4M 145.6M 165.3M 154.3M 140.4M 173.6M 204.2M 229.3M 458.2M 260.6M 320.4M 512.6M 630.8M 311.9M 385.5M 285.2M 315.7M 301.1M 445.8M 363.7M 383M 247.6M
Income Tax Expense
13.9M 6.6M 3.9M 6.4M -4.8M 24.7M 3.7M 27.6M 13.3M 3.1M -5M -2.5M 11.2M 25.6M 5.6M 19.9M -32.8M -100K 78.2M -12.8M 2.6M 15.5M
Shares Outstanding (Basic)
51.6M 51.9M 52.4M 53.2M 54.2M 54.4M 54.2M 53.1M 52.6M 52.2M 51.9M 51.8M 50.7M 50.2M 49.9M 49.8M 49.91M 50.7M 53.2M 53.61M 53.6M 53.3M
Shares Outstanding (Diluted)
51.6M 56.5M 52.4M 56.5M 54.2M 57.3M 54.2M 55.6M 52.6M 52.2M 51.9M 51.8M 50.7M 50.2M 49.9M 49.9M 50M 50.7M 53.5M 53.7M 54M 54.5M
EPS (Basic)
-3.49 0.13 -1.04 0.96 -0.22 1.25 -0.59 2.16 -5.38 0.17 -0.95 -5.13 -5.15 -3.65 -1.76 -1.52 -1.13 -0.07 3.54 -0.61 0.09 1.31
EPS (Diluted)
-3.49 0.07 -1.04 0.91 -0.22 1.19 -0.59 2.06 -5.38 0.17 -0.95 -5.13 -5.15 -3.65 -1.76 -1.52 -1.13 -0.07 3.50 -0.61 0.09 1.28
EBITDA
-156.3M 48.5M -12.5M 96.6M 21.9M 133.4M 21M 97.7M -131.5M 63.4M -13.5M 23.3M 48M -104.1M 24.6M -1.2M -44.1M 36.4M 347.2M -2.5M 47.5M 123.9M
EBIT
-156.3M 24.4M -36M 72.8M -2.1M 107.4M -4.3M 72M -159.1M 36.4M -42.2M -3.6M 16M -137.6M 3M -44.7M -74.5M 6.9M 319.4M -33.8M 15.8M 96.5M
Depreciation & Amortization
n/a 24.1M 23.5M 23.8M 24M 26M 25.3M 25.7M 27.6M 27M 28.7M 26.9M 32M 33.5M 21.6M 43.5M 30.4M 29.5M 27.8M 31.3M 31.7M 27.4M

© 2026 bestshares.com. All rights reserved.